Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 60
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ann Intern Med ; 176(3): JC35, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36877977

RESUMEN

SOURCE CITATION: Hammond NE, Myburgh J, Seppelt I, et al. Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA. 2022;328:1922-34. 36286098.


Asunto(s)
Antibacterianos , Infección Hospitalaria , Humanos , Adulto , Antibacterianos/uso terapéutico , Mortalidad Hospitalaria , Respiración Artificial , Descontaminación , Infección Hospitalaria/tratamiento farmacológico , Tracto Gastrointestinal , Unidades de Cuidados Intensivos
2.
Crit Care Med ; 51(11): 1570-1586, 2023 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-37902340

RESUMEN

RATIONALE: Fever is frequently an early indicator of infection and often requires rigorous diagnostic evaluation. OBJECTIVES: This is an update of the 2008 Infectious Diseases Society of America and Society (IDSA) and Society of Critical Care Medicine (SCCM) guideline for the evaluation of new-onset fever in adult ICU patients without severe immunocompromise, now using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. PANEL DESIGN: The SCCM and IDSA convened a taskforce to update the 2008 version of the guideline for the evaluation of new fever in critically ill adult patients, which included expert clinicians as well as methodologists from the Guidelines in Intensive Care, Development and Evaluation Group. The guidelines committee consisted of 12 experts in critical care, infectious diseases, clinical microbiology, organ transplantation, public health, clinical research, and health policy and administration. All task force members followed all conflict-of-interest procedures as documented in the American College of Critical Care Medicine/SCCM Standard Operating Procedures Manual and the IDSA. There was no industry input or funding to produce this guideline. METHODS: We conducted a systematic review for each population, intervention, comparison, and outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the GRADE approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak or as best-practice statements. RESULTS: The panel issued 12 recommendations and 9 best practice statements. The panel recommended using central temperature monitoring methods, including thermistors for pulmonary artery catheters, bladder catheters, or esophageal balloon thermistors when these devices are in place or accurate temperature measurements are critical for diagnosis and management. For patients without these devices in place, oral or rectal temperatures over other temperature measurement methods that are less reliable such as axillary or tympanic membrane temperatures, noninvasive temporal artery thermometers, or chemical dot thermometers were recommended. Imaging studies including ultrasonography were recommended in addition to microbiological evaluation using rapid diagnostic testing strategies. Biomarkers were recommended to assist in guiding the discontinuation of antimicrobial therapy. All recommendations issued were weak based on the quality of data. CONCLUSIONS: The guidelines panel was able to formulate several recommendations for the evaluation of new fever in a critically ill adult patient, acknowledging that most recommendations were based on weak evidence. This highlights the need for the rapid advancement of research in all aspects of this issue-including better noninvasive methods to measure core body temperature, the use of diagnostic imaging, advances in microbiology including molecular testing, and the use of biomarkers.


Asunto(s)
Enfermedades Transmisibles , Enfermedad Crítica , Humanos , Adulto , Enfermedad Crítica/terapia , Fiebre/diagnóstico , Cuidados Críticos/métodos , Unidades de Cuidados Intensivos , Biomarcadores
5.
Anesthesiology ; 132(3): 586-597, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31841446

RESUMEN

Although clinical guidelines for antibiotic prophylaxis across a wide array of surgical procedures have been proposed by multidisciplinary groups of physicians and pharmacists, clinicians often deviate from recommendations. This is particularly true when recommendations are based on weak data or expert opinion. The goal of this review is to highlight certain common but controversial topics in perioperative prophylaxis and to focus on the data that does exist for the recommendations being made.


Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica/métodos , Infección de la Herida Quirúrgica/prevención & control , Antibacterianos/administración & dosificación , Farmacorresistencia Bacteriana , Humanos , Atención Perioperativa , Factores de Riesgo , Infección de la Herida Quirúrgica/microbiología
7.
Crit Care Med ; 51(6): 835-837, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-37199553
9.
Clin Infect Dis ; 63(7): 868-875, 2016 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-27358351

RESUMEN

BACKGROUND: An increasing number of physicians are seeking dual training in critical care medicine (CCM) and infectious diseases (ID). Understanding experiences and perceptions of CCM-ID physicians could inform career choices and programmatic innovation. METHODS: All physicians trained and/or certified in both CCM and ID to date in the United States were sent a Web-based questionnaire in 2015. Responses enabled a cross-sectional analysis of physician demographics and training and practice characteristics and satisfaction. RESULTS: Of 202 CCM-ID physicians, 196 were alive and reachable. The response rate was 79%. Forty-six percent trained and 34% practice in the northeastern United States. Only 40% received dual training at the same institution. Eighty-three percent identified as either an intensivist with ID expertise (44%) or as equally an intensivist and ID physician (38%). Median salary was $265 000 (interquartile range [IQR], $215 000-$350 000). Practice settings were split between academic (45%) and community settings (42%). Two-thirds are clinicians but 62% conduct some research and 26% practice outpatient ID. Top reasons to dually specialize included clinical synergy (70%), procedural activity (50%), and less interest in pulmonology (49%). Although 38% cited less proficiency with bronchoscopy as a disadvantage, 87% seldom need pulmonary consultation in the intensive care unit. Median career satisfaction was 4 (IQR, 4-5) out of 5, and 76% would dually train again. CONCLUSIONS: CCM-ID graduates prefer the acute care setting, predominantly CCM or a combination of CCM and ID. They find combination training and practice to be synergistic and satisfying, but most have had to seek CCM and ID training independently at separate institutions. Given these findings, avenues for combined training in CCM-ID should be considered.


Asunto(s)
Cuidados Críticos , Infectología , Médicos , Adulto , Estudios Transversales , Femenino , Humanos , Infectología/economía , Infectología/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Satisfacción Personal , Médicos/economía , Médicos/psicología , Médicos/estadística & datos numéricos , Encuestas y Cuestionarios , Estados Unidos
10.
Clin Infect Dis ; 63(5): e61-e111, 2016 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-27418577

RESUMEN

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.


Asunto(s)
Infección Hospitalaria/diagnóstico , Infección Hospitalaria/terapia , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/terapia , Neumonía Asociada al Ventilador/diagnóstico , Neumonía Asociada al Ventilador/terapia , Adulto , Antibacterianos/uso terapéutico , Técnicas Bacteriológicas , Farmacorresistencia Bacteriana Múltiple , Humanos , Estados Unidos
11.
Clin Infect Dis ; 63(5): 575-82, 2016 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-27521441

RESUMEN

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.


Asunto(s)
Infección Hospitalaria/diagnóstico , Infección Hospitalaria/terapia , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/terapia , Neumonía Asociada al Ventilador/diagnóstico , Neumonía Asociada al Ventilador/terapia , Adulto , Antibacterianos/uso terapéutico , Técnicas Bacteriológicas , Farmacorresistencia Bacteriana Múltiple , Humanos , Guías de Práctica Clínica como Asunto , Estados Unidos
12.
Ann Intern Med ; 163(6 Suppl): S1-40, 2015 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-26369828

RESUMEN

Use of peripherally inserted central catheters (PICCs) has grown substantially in recent years. Increasing use has led to the realization that PICCs are associated with important complications, including thrombosis and infection. Moreover, some PICCs may not be placed for clinically valid reasons. Defining appropriate indications for insertion, maintenance, and care of PICCs is thus important for patient safety. An international panel was convened that applied the RAND/UCLA Appropriateness Method to develop criteria for use of PICCs. After systematic reviews of the literature, scenarios related to PICC use, care, and maintenance were developed according to patient population (for example, general hospitalized, critically ill, cancer, kidney disease), indication for insertion (infusion of peripherally compatible infusates vs. vesicants), and duration of use (≤5 days, 6 to 14 days, 15 to 30 days, or ≥31 days). Within each scenario, appropriateness of PICC use was compared with that of other venous access devices. After review of 665 scenarios, 253 (38%) were rated as appropriate, 124 (19%) as neutral/uncertain, and 288 (43%) as inappropriate. For peripherally compatible infusions, PICC use was rated as inappropriate when the proposed duration of use was 5 or fewer days. Midline catheters and ultrasonography-guided peripheral intravenous catheters were preferred to PICCs for use between 6 and 14 days. In critically ill patients, nontunneled central venous catheters were preferred over PICCs when 14 or fewer days of use were likely. In patients with cancer, PICCs were rated as appropriate for irritant or vesicant infusion, regardless of duration. The panel of experts used a validated method to develop appropriate indications for PICC use across patient populations. These criteria can be used to improve care, inform quality improvement efforts, and advance the safety of medical patients.


Asunto(s)
Cateterismo Venoso Central/estadística & datos numéricos , Cateterismo Periférico/estadística & datos numéricos , Cateterismo Venoso Central/efectos adversos , Cateterismo Venoso Central/instrumentación , Cateterismo Periférico/efectos adversos , Cateterismo Periférico/instrumentación , Enfermedad Crítica/terapia , Remoción de Dispositivos , Hospitalización , Humanos , Michigan , Neoplasias/terapia , Insuficiencia Renal Crónica/terapia , Procedimientos Innecesarios
13.
Clin Infect Dis ; 61(4): 609-14, 2015 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-25944345

RESUMEN

The recent rise in unfilled training positions among infectious diseases (ID) fellowship programs nationwide indicates that ID is declining as a career choice among internal medicine residency graduates. Supplementing ID training with training in critical care medicine (CCM) might be a way to regenerate interest in the specialty. Hands-on patient care and higher salaries are obvious attractions. High infection prevalence and antibiotic resistance in intensive care units, expanding immunosuppressed host populations, and public health crises such as the recent Ebola outbreak underscore the potential synergy of CCM-ID training. Most intensivists receive training in pulmonary medicine and only 1% of current board-certified intensivists are trained in ID. While still small, this cohort of CCM-ID certified physicians has continued to rise over the last 2 decades. ID and CCM program leadership nationwide must recognize these trends and the merits of the CCM-ID combination to facilitate creation of formal dual-training opportunities.


Asunto(s)
Enfermedades Transmisibles/diagnóstico , Enfermedades Transmisibles/tratamiento farmacológico , Cuidados Críticos/métodos , Infectología/métodos , Medicina/métodos , Educación Médica/tendencias , Humanos , Infectología/educación , Estados Unidos
14.
N Engl J Med ; 364(15): 1407-18, 2011 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-21488763

RESUMEN

BACKGROUND: Intensive care units (ICUs) are high-risk settings for the transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). METHODS: In a cluster-randomized trial, we evaluated the effect of surveillance for MRSA and VRE colonization and of the expanded use of barrier precautions (intervention) as compared with existing practice (control) on the incidence of MRSA or VRE colonization or infection in adult ICUs. Surveillance cultures were obtained from patients in all participating ICUs; the results were reported only to ICUs assigned to the intervention. In intervention ICUs, patients who were colonized or infected with MRSA or VRE were assigned to care with contact precautions; all the other patients were assigned to care with universal gloving until their discharge or until surveillance cultures obtained at admission were reported to be negative. RESULTS: During a 6-month intervention period, there were 5434 admissions to 10 intervention ICUs, and 3705 admissions to 8 control ICUs. Patients who were colonized or infected with MRSA or VRE were assigned to barrier precautions more frequently in intervention ICUs than in control ICUs (a median of 92% of ICU days with either contact precautions or universal gloving [51% with contact precautions and 43% with universal gloving] in intervention ICUs vs. a median of 38% of ICU days with contact precautions in control ICUs, P<0.001). In intervention ICUs, health care providers used clean gloves, gowns, and hand hygiene less frequently than required for contacts with patients assigned to barrier precautions; when contact precautions were specified, gloves were used for a median of 82% of contacts, gowns for 77% of contacts, and hand hygiene after 69% of contacts, and when universal gloving was specified, gloves were used for a median of 72% of contacts and hand hygiene after 62% of contacts. The mean (±SE) ICU-level incidence of events of colonization or infection with MRSA or VRE per 1000 patient-days at risk, adjusted for baseline incidence, did not differ significantly between the intervention and control ICUs (40.4±3.3 and 35.6±3.7 in the two groups, respectively; P=0.35). CONCLUSIONS: The intervention was not effective in reducing the transmission of MRSA or VRE, although the use of barrier precautions by providers was less than what was required. (Funded by the National Institute of Allergy and Infectious Diseases and others; STAR*ICU ClinicalTrials.gov number, NCT00100386.).


Asunto(s)
Infección Hospitalaria/transmisión , Transmisión de Enfermedad Infecciosa/prevención & control , Infecciones por Bacterias Grampositivas/transmisión , Control de Infecciones/métodos , Unidades de Cuidados Intensivos , Staphylococcus aureus Resistente a Meticilina , Resistencia a la Vancomicina , Antibacterianos/uso terapéutico , Recuento de Colonia Microbiana , Infección Hospitalaria/prevención & control , Enterococcus/efectos de los fármacos , Guantes Protectores/estadística & datos numéricos , Infecciones por Bacterias Grampositivas/microbiología , Infecciones por Bacterias Grampositivas/prevención & control , Desinfección de las Manos , Humanos , Aislamiento de Pacientes , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/prevención & control , Infecciones Estafilocócicas/transmisión , Vestimenta Quirúrgica/estadística & datos numéricos
15.
J Vasc Interv Radiol ; 25(5): 797-802, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24745908

RESUMEN

PURPOSE: To design, prototype, and assess a custom vascular access catheter for its ability to inhibit bacterial colonization in vitro and to optimize electric parameters for efficacy and safe translation. MATERIALS AND METHODS: A vascular access catheter with conductive elements was designed and custom fabricated with two electrodes at the tip, separated by a nonconductive segment. The catheter was colonized with Staphylococcus aureus and incubated at predetermined current levels (4-8 µA) and durations (4-24 h). Catheters were compared using bacterial counts and scanning electron microscopy (SEM). RESULTS: Bacteria colony-forming units were reduced significantly (P < .05) by > 90% (91.7%-100%) in all uninterrupted treatment arms that included electric current (4 µA or 8 µA) of at least 8 hours' duration. Qualitative analysis using SEM revealed that the treated catheter exposed to electric current had markedly less bacteria compared with the untreated catheter. CONCLUSIONS: This catheter with conductive elements inhibits bacterial colonization in vitro when very small electric current (4-8 µA) is applied across the tip for 8-24 hours. In vivo validation is requisite to future translation to the clinical setting.


Asunto(s)
Infecciones Relacionadas con Catéteres/prevención & control , Catéteres Venosos Centrales/microbiología , Estimulación Eléctrica/instrumentación , Contaminación de Equipos/prevención & control , Infecciones Estafilocócicas/prevención & control , Staphylococcus aureus/crecimiento & desarrollo , Esterilización/instrumentación , Infecciones Relacionadas con Catéteres/microbiología , Supervivencia Celular/efectos de la radiación , Diseño de Equipo , Análisis de Falla de Equipo , Humanos , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/efectos de la radiación
19.
JAMA ; 307(23): 2534-9, 2012 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-22797453

RESUMEN

Ventilator-associated pneumonia (VAP) is among the most common infections in patients requiring endotracheal tubes with mechanical ventilation. Ventilator-associated pneumonia is associated with increased hospital costs, a greater number of days in the intensive care unit, longer duration of mechanical ventilation, and higher mortality. Despite widely accepted recommendations for interventions designed to reduce rates of VAP, few studies have assessed the ability of these interventions to improve patient outcomes. As the understanding of VAP advances and new technologies to reduce VAP become available, studies should directly assess patient outcomes before the health care community implements specific prevention approaches in clinical practice.


Asunto(s)
Medicina Basada en la Evidencia , Neumonía Asociada al Ventilador/prevención & control , Respiración Artificial/métodos , Cateterismo , Clostridioides difficile , Terapia Combinada , Enterocolitis Seudomembranosa , Femenino , Neoplasias Hematológicas/cirugía , Humanos , Pulmón/patología , Moco , Neumonía Asociada al Ventilador/epidemiología , Neumonía Asociada al Ventilador/patología , Postura , Factores de Riesgo , Trasplante de Células Madre , Succión
20.
Infect Dis Clin North Am ; 36(4): 735-748, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36328633

RESUMEN

Both cytokine release syndrome (CRS) and sepsis are clinical syndromes rather than distinct diseases and share considerable overlap. It can often be challenging to distinguish between the two, but it is important given the availability of targeted treatment options. In addition, several other clinical syndromes overlap with CRS and sepsis, further making it difficult to differentiate them. This has particularly been highlighted in the recent coronavirus disease-2019 pandemic. As we start to understand the differences in the inflammatory markers and presentations in these syndromes, hopefully we will be able to enhance treatment and improve outcomes.


Asunto(s)
COVID-19 , Sepsis , Humanos , Síndrome de Liberación de Citoquinas/etiología , Anticuerpos Monoclonales Humanizados/uso terapéutico , Interleucina-6 , Sepsis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA